Is Estrella Immunopharma, Inc. (ESLA) a Buy, Sell, or Hold?
NASDAQ : ESLA
Estrella Immunopharma, Inc. — Competitors
$0.7196 USD
$0.0 (-0.41%)
- Volume
- 18.19K
- Average Volume
- 39.19K
- Market Capitalization
- $30.7M
- P/E Ratio
- -2.08
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.15
- Year Low
- $0.68
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.24
ESLA vs. The Competition
| Properties | ESLA | ANEB | ATOS | EXOZ |
|---|---|---|---|---|
| Market Cap | $30.7M | $12.24M | $24.04M | $50.86M |
| Shares Outstanding | $42.67M | $40.78M | $9.98M | $9.28M |
| P/E Ratio | -2.08 | -1.54 | -0.56 | -4.77 |
| EPS | -0.31 | -0.19 | -4.23 | -1.14 |
| Day Low | 0.719 | 0.3 | 2.335 | 5.12 |
| Day High | 0.8096 | 0.3 | 2.44 | 5.49 |
| Year Low | 0.678 | 0.001 | 1.7 | 4.35 |
| Year High | 3.15 | 2.9 | 19.35 | 18.4 |
| Average Price 50 | 0.92306 | 0.361 | 2.7508 | 6.9819 |
| Average Price 200 | 1.36811 | 0.9901 | 6.6274 | 10.01312 |
| Volume | 18188.98 | - | 63381 | 1050.79 |
| Average Volume | - | - | - | - |